oxybutynin has been researched along with Hypopituitarism in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Hypopituitarism: Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, E | 1 |
| McCabe, E | 1 |
| Newton-Cheh, C | 1 |
| Bloch, K | 1 |
| Buys, E | 1 |
| Wang, T | 1 |
| Miller, KK | 1 |
| Birzniece, V | 1 |
| Ho, KK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| TheraDerm Administration in Women With Hypopituitarism[NCT00027430] | 50 participants (Anticipated) | Interventional | 2001-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for oxybutynin and Hypopituitarism
| Article | Year |
|---|---|
Effects of transdermal testosterone on natriuretic peptide levels in women: a randomized placebo-controlled pilot study.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Androgens; Biomarkers; Boston; Double-Blind | 2012 |
1 other study available for oxybutynin and Hypopituitarism
| Article | Year |
|---|---|
Growth and development: patching up a better pill for GH-deficient women.
Topics: Estrogen Replacement Therapy; Female; Human Growth Hormone; Humans; Hypopituitarism; Transdermal Pat | 2012 |